Product Categories
-
Quality Control – Rapid Inspection Equipment
-
Quality Control – Pharmaceutical Inspection
-
Quality Control - Food Inspection
-
Research culture media products
-
Research and Development - Drug Discovery and Regenerative Medicine
-
Research and Development - Clinical Trials
-
Formulation research and CMO of injectable preparations
Featured products
Products/Services(45items)
news list
-
★Opening of the Question Box★【Point Explanation】 Culture Medium Performance Test Handbook
We have opened a question box on the popular special site "Point Explanation" for the media performance test manual. We will publish questions and answers/explanations that may help those who have similar questions or doubts (the content of the questions has been edited). Please feel free to use it along with inquiries when you have questions or doubts about the media performance test.
-
December 5th (Thursday) to 6th (Friday), 2024 - Notice of participation in the 31st Annual Meeting of the Japan PDA Pharmaceutical Science Society (Tokyo)
Japan BD will be exhibiting at the "31st Annual Meeting of the Japan PDA Pharmaceutical Science Society (Tokyo)" held at Tower Hall Funabori. This year's meeting will focus on themes related to pharmaceutical and formulation technology, as well as GMP and validation, featuring special lectures and general presentations over two days, alongside symposiums. Topics such as regulatory science and examples of validation implementation will be presented. This year's theme is "Stable Supply - Ensuring Quality and New Technologies." Exhibits will include BD's drug delivery systems (DDS) for injectable drugs, testing services required for combination drug development, and media for quality control. We sincerely look forward to your visit.
-
[Lesson 3 Announcement] Point Explanation Culture Medium Performance Test Handbook
We have released Lesson 3 of the web course "Key Points Explanation: Media Performance Testing Manual." Lesson 3 is titled "18th Revision of the Japanese Pharmacopoeia: 4.05 Microbial Limit Testing - Media Performance Testing in Specific Microbial Tests." ≪What is the "Key Points Explanation: Media Performance Testing Manual"?≫ This is a series where experts clearly explain key points for each test, covering the basics to applications of media performance testing. We will provide you with "essential points to keep in mind" for reliable and efficient quality control. Please feel free to stop by.
-
Announcement of the opening of a dedicated website for microbiological testing solutions for pharmaceuticals.
We have launched a dedicated website for our microbiological testing solutions for pharmaceuticals, titled "Global Media Brand BD BBL (TM) Media / BD Difco (TM) Media in Compliance with the Pharmacopoeia of the Three Regions." As an information site for the global media brands BD BBL (TM) Media / BD Difco (TM) that comply with the standards of the Japanese Pharmacopoeia, United States Pharmacopeia, and European Pharmacopoeia, we will continue to enhance our content. If you have any inquiries or need product information (data, etc.), please feel free to contact us. A dedicated representative will assist you. We appreciate your continued support of Japan BD.

About日本ベクトン・ディッキンソン
品質管理・研究開発・注射剤の製剤研究・CMO
Tomorrow's healthcare for everyone (TM)
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.